Nilkamal Limited — Others, 14-05-2025: Shareholders meeting

Nilkamal Limited has announced a board meeting outcome approving the financial results for the quarter and financial year ended March 31, 2025. Standalone revenue grew 3% to ₹3,239 Cr with PAT of ₹91 Cr. The B2B segment rose 5% in volume and value, while Retail & E-commerce declined 7%; e-commerce grew 10%, offset by a 17% drop in retail stores due to rebranding. Capex stood at ₹280 Cr, focusing on new manufacturing for modular furniture, foam, and packaging. Net borrowing increased to ₹272 Cr. A final dividend of ₹20 per share was declared. The company expanded into medical furniture by acquiring Imedfurns’ healthcare business for ₹4 Cr payable over four years. Subsidiaries in Sri Lanka improved, UAE was flat, and the US joint venture earned ₹16 Cr profit on ₹131 Cr revenue. The Retail segment faced an EBIT loss of ₹35 Cr due to brand-building investments supporting future growth.